IDH1 and astrocytoma (excluding glioblastoma): PCV is often preferred over TMZ for IDH-mutant oligodendrogliomas and CNS WHO grade 2 IDH-mutant astrocytoma and vice versa for CNS WHO grade 3 IDH-mutant astrocytoma (79).